Marigold Pharma announces significant infrastructure enhancements at its Solapur MIDC manufacturing unit to support commercial-scale synthesis of high-purity APIs, peptide coupling, and advanced intermediates.
Exploring scalable solid-phase peptide synthesis (SPPS) and preparative HPLC purification techniques for complex generic formulations adhering to stringent international pharmacopoeias.
How our fully integrated contract development and manufacturing organization (CDMO) assists pharmaceutical partners from process development to global cGMP commercial batch manufacturing.
